These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 11763156)

  • 1. Personalized medicine-concepts, technologies, and applications in inflammatory skin diseases.
    Litman T
    APMIS; 2019 May; 127(5):386-424. PubMed ID: 31124204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of PMA-induced skin inflammation involves interaction of IFN-γ and ALOX15.
    Zhang G; Liu X; Wang C; Qu L; Deng J; Wang H; Qin Z
    Mediators Inflamm; 2013; 2013():930124. PubMed ID: 23818745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution.
    Singh N; Jabeen T; Somvanshi RK; Sharma S; Dey S; Singh TP
    Biochemistry; 2004 Nov; 43(46):14577-83. PubMed ID: 15544328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases.
    von Bonin A; Rausch A; Mengel A; Hitchcock M; Krüger M; von Ahsen O; Merz C; Röse L; Stock C; Martin SF; Leder G; Döcke WD; Asadullah K; Zügel U
    Exp Dermatol; 2011 Jan; 20(1):41-7. PubMed ID: 21158938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cytosolic phospholipase A2 by arachidonyl trifluoromethyl ketone prevents chronic inflammation in mice.
    Malaviya R; Ansell J; Hall L; Fahmy M; Argentieri RL; Olini GC; Pereira DW; Sur R; Cavender D
    Eur J Pharmacol; 2006 Jun; 539(3):195-204. PubMed ID: 16712837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting phospholipase A2 for the treatment of inflammatory skin diseases.
    Burke JR
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1549-52. PubMed ID: 11763156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory phospholipase A2 inhibitors. Possible new anti-inflammatory agents.
    Tanaka K; Arita H
    Agents Actions Suppl; 1995; 46():51-64. PubMed ID: 7610991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipase A2 expression in tumours: a target for therapeutic intervention?
    Laye JP; Gill JH
    Drug Discov Today; 2003 Aug; 8(15):710-6. PubMed ID: 12927514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes].
    Kolko M; Zhan C; Andreasen JR; Prause JU; Heegaard S
    Ugeskr Laeger; 2007 Jan; 169(2):115-9. PubMed ID: 17227656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid inhibitors of phospholipase A2].
    Bragina NA; Chupin VV; Bulgakov VG; Shal'nev AN
    Bioorg Khim; 1999 Feb; 25(2):83-96. PubMed ID: 10495898
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.